Prevalence of extended spectrum beta-lactamase production among uropathogens in south Mumbai and its antibiogram pattern

EXCLI Journal

Volumn 11, Issue , 2012, Pages 363-372

  Aruna, K ^a   Mobashshera, T ^a  

^a WILSON COLLEGE   (India)

Author keywords

lactam; Drug resistance; ESBL; Uropathogens

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFADROXIL; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; OXYTETRACYCLINE; PIPERACILLIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TICARCILLIN; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CITROBACTER; CITROBACTER AMALONATICUS; CITROBACTER KOSERI; CONTROLLED STUDY; DISK DIFFUSION; DOUBLE DISK SYNERGY TEST; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ENZYME SYNTHESIS; EPSILOMETER TEST; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; INDIA; KLEBSIELLA PNEUMONIAE; MORGANELLA MORGANII; NONHUMAN; PHENOTYPIC CONFIRMATORY DISK DIFFUSION TEST; PREVALENCE; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SCREENING TEST; TEST STRIP; URINALYSIS;

EID: 84867606724     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Adams M, Tavakoli H. Gatifloxacininduced hallucinations in a 19-year-old man. Psychosomatics 2006;47:360.
2. Aggarwal R, Chaudhary U, Sikka R. Detection of extended spectrum beta-lactamase production among uropathogens. J Lab Physicians 2009;1:7-10.
3. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community acquired urinary tract infections in JNMC Hospital Aligarh. Ann Clin Microbiol Antimicrob 2007;6:4.
4. Ananthan S, Subha A. Cefoxitin resistance mediated by loss of a porin in clinical strains of Klebsiella pneumoniae and Escherichia coli. Indian J Med Microbiol 2005;23:20-3.
5. Arpin C, Dubois V, Coulange L, André C, Fischer I, Noury P et al. Extendedspectrum ß-lactamase producing Enterobacteriaceae in community and private health care centres. Antimicrob Agents Chemother 2003;47:3506-14.
6. Borer A, Gilad J, Menashe G, Peled N, Riesenberg K, Schlaeffer F. Extendedspectrum beta-lactamase producing Enterobacteriacea strains in community-acquired bacteremia in Southern Israel. Med Sci Monit 2002;8(1):CR44-7.
7. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;48:933-51.
8. Burka JM, Bower K, Vanroekel R, Stutzman R, Kuzmowych C, Howard R. The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy. Am J Ophthalmol 2005;140: 83-7.
9. Cendron M. Antibiotic prophylaxis in the management of vesicoureteral reflux. Adv Urol 2008; article id 825475 (6 pp).
10. Chaudhary U, Aggarwal R. Extended spectrum-lactamases (ESBL)-an emerging threat to clinical therapeutics. Indian J Med Microbiol 2004;22:75-80.
11. CLSI. Performance standards for antimicrobial susceptibility tests. Twentieth informational supplemented. CLSI 2010; document M100-S20.
12. CLSI. Performance standards for antimicrobial disc susceptibility tests; Vol. 31 No. 1. CLSI 2011; document M100-S21.
13. CLSI. Performance standards for antimicrobial disc susceptibility tests; approved standard-11th ed., CLSI 2012; document M02-A11.
14. Coleman C, Spencer J, Chung J, Reddy P. Possible gatifloxacin-induced fulminant hepatic failure. Ann Pharmacother 2002; 36:1162-7.
15. Collee JG, Fraser AG, Marmion BP, Simmons A (eds): Mackie & McCartney practical medical microbiology, 14th ed (pp 361-81; 417-23). London: Churchill Livingstone, 1996.
16. Fukuda H, Hiramatsu K. Mechanisms of endogenous drug resistance acquisition by spontaneous chromosomal gene mutation. Nihon Rinsho 1997;55:1185-90 [in Japanese].
17. Gales A, Sader H, Jones R, SENTRY participants group (Latin America). Urinary tract infection's trends in the American hospitals: reports from the SENTRY Antimicrobial Surveillance programme (1997-2000). Diagn Microbial Infect Dis 2002; 44:289-99.
18. Giriyapur R, Nandihal N, Krishna B, Patil A, Chandrasekhar M. Comparison of discdiffusion methods for the detection of extended-spectrum beta lactamase-producing Enterobacteriaceae. J Lab Physicians 2011; 3:33-6.
19. Gonzalez C, Schaeffer A. Treatment of urinary tract infection: what's old, what's new, and what works. World J Urol 1999; 17:372-82.
20. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999;281:736-8.
21. Gupta N, Kundra S, Sharma A, Gautam V, Arora DR. Antimicrobial susceptibility of uropathogens in India. J Infect Dis Antimicrob Agents 2007; 24:13-8.
22. Gururajan G, Kathireshan A, Kaliyaperumal, Balagurunathan R. Prevalence of extended spectrum beta lactamases in uropathogenic Escherichia coli and Klebsiella species in a Chennai suburban tertiary care hospital and its antibiogram pattern. Res J Microbiol 2011;6:796-804.
23. Hsueh PR, Hoban DJ, Carmeli Y, Chen SY, Desikan S, Alejandria M et al. Consensus review of epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Infect 2011;63:114-23.
24. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10:867-78.
25. Jemima SA, Verghese S. Molecular characterization of nosocomial CTX-M type beta-lactamases producing Enterobacteriaceae from a tertiary care hospital in South India. Indian J Med Microbiol 2008;26: 356-8.
26. Kamatchi C, Magesh H, Sekhar U, Vaidyanathan R. Identification of clonal clusters of Klebsiella pneumoniae isolates from Chennai by extended spectrum beta lactamase genotyping and antibiotic resistance phenotyping analysis. Am J Infect Dis 2009;5:74-82.
27. Karim A, Poirel S, Nagarajan, Nordmann P. Plasmid mediated extended-spectrum beta-lactamase from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 2001;201:237-41.
28. Kassis-Chikhani N, Vimont S, Asselat K, Trivalle C, Minassian B, Sengelin C et al. CTX-M β-lactamase-producing Escherichia coli in long-term care facilities, France. Emerg Infect Dis 2004;10:1697-8.
29. Mano JV, Vasanthi S. Detection of extended spectrum beta lactamases (ESBL) in the family of enterobacteriaceae at rural hospital. Indian J Med Res 2008;127:671.
30. Mathai D, Rhomberg PR, Biedenbach DJ, Jones RN. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against recent clinical isolates from India: A survey of ten medical center laboratories. Diagn Microbiol Infect Dis 2002;44:367-77.
31. Mathur P, Tatman A, Das B, Dhawan B. Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital. Indian J Med Res 2002;115:153-7.
32. Maya AS, Prabhakar K, Hanna LE, Sarayu YL. Phenotypic and genotypic characterization of extended-spectrum beta-lactamase producing Escherichia coli clinical isolates from Semi urban Area. J Pharm Res 2011;4:6-10.
33. Mazzuli T. Resistance trends in urinary tract pathogens and impact on management. J Urol 2002;168:1720-2.
34. Menon T, Bindu D, Kumar CP, Nalini S, Thirunarayan MA. Comparison of double disc and three dimensional methods to screen for ESBL producers in a tertiary care hospital. Indian J Med Microbiol 2006;24:117-20.
35. Narayanaswamy A, Mallika M. Prevalence of extended spectrum beta lactamases in urinary isolates of Escherichia coli in a tertiary care hospital, Chennai, South India. Internet J Med 2011;6:39-43.
36. Padmini SB, Raju BA. Extended spectrum β-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae-prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol 2004;22:172-4.
37. Padmini SB, Raju BA, Mani KR. Detection of Enterobacteriacea producing CTXM extended spectrum β-lactamases from a tertiary care hospital in South India. Indian J Med Microbiol 2008;26:163-6.
38. Park-Wyllie LY, Juurlink DN, Kopp A, Shah BR, Stukel TA, Stumpo C et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006; 354:1352-61.
39. Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB. Extendedspectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV-and CTX-Mtype beta-lactamases. Antimicrob Agents Chemother 2003;47:3554-60.
40. Philippon A, Arlet G, Jacoby GA. Plasmiddetermined AmpC type β-lactamases. Antimicrob Agents Chemother 2002;46:1-11.
41. Revathi G, Singh S. Detection of expanded spectrum cephalosporin resistance due to inducible lactamases in hospital isolates. Indian J Med Microbiol 1997;15:113-5.
42. Shukla I, Tiwari R, Agrawal M. Prevalence of extended spectrum β-lactamase producing Klebsiella pneumoniae in a tertiary care hospital. Indian J Med Microbiol 2004;22:87-9.
43. Tambekar D, Dhanorkar D, Gulhane S, Khandelwal V, Dudhane M. Antibacterial susceptibility of some urinary tract pathogens to commonly used antibiotics. Afr J Biotechnol 2006;5:1562-5.
44. Truls E, Bjerklund J. Hospital acquired urinary tract infections in urology departments: Pathogens, susceptibility and use of antibiotics. Int J Antimicrob Agents 2006; 28S:S91-107.
45. Wiener J, Quinn J, Bradford P, Goering R, Nathan C, Bush K. Multiple antibioticresistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999;281:517-23.
46. Zaman G, Karamat KA, Abbasi S, Rafi S, Ikram A. Prevalence of extended-spectrum beta-lactamase (ESBL) producing enterobacteriaceae in nosocomial isolates. Pak Armed Forces Med J 1999;49:91-6.